Last week, the U.S. Food and Drug Administration (FDA) approved Perseris (risperidone), an injectable version of risperidone, for extended treatment of adult schizophrenia. After the drug is injected just under the skin in a person’s abdomen, the treatment appears to be effective for 30 days in adults. Risperidone is an atypical antipsychotic often prescribed for the treatment of schizophrenia.
Schizophrenia is a potentially debilitating mental illness in the people it strikes, resulting...
[Read More ...]
source https://psychcentral.com/news/2018/07/30/perseris-risperidone-approved-for-once-monthly-schizophrenia-treatment/137449.html
No comments:
Post a Comment